Researchers puzzle over whether HIV accelerates cancer progression
8-week course of Zepatier cures acute HCV in people with HIV
Integrase inhibitors do not raise risk of IRIS in severely immunocompromised people
South Africa: women may have higher rates of HIV than men because fewer men are on treatment
Switching from abacavir to TAF improves platelet function
Research sheds more light on cardiovascular risk in people with HIV
Older people in United States more likely to have AIDS at the time of HIV diagnosis
Age difference in HIV infection matters – but it’s not always the younger person who is at risk
New South Wales puts 9000 people on PrEP, achieves a one-third decline in new HIV infections
Failure of second-line ART is common in resource-limited countries, but modern third-line regimens work well
Lesotho making strong progress towards 90-90-90 targets
Very early treatment in children limits the HIV reservoir
Isoniazid preventive therapy: do the risks outweigh the benefits in pregnant women with HIV?
Treatment with extended-release naltrexone increases chances that HIV-positive prisoners will maintain viral suppression after release
Powerful new PrEP and treatment drug should be effective as a small weekly pill
High uptake of HIV self-testing by men who have sex with men and transgender women in Burma
Another possible case of PrEP 'breakthrough' infection reported
How much 'PrEP-resistant' HIV is out there?
